Information Journal Paper
APA:
Copy. (2022). Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells. HEMATOLOGY, 27(1), 43-52. SID. https://sid.ir/paper/1114045/en
Vancouver:
Copy. Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells. HEMATOLOGY[Internet]. 2022;27(1):43-52. Available from: https://sid.ir/paper/1114045/en
IEEE:
Copy, “Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells,” HEMATOLOGY, vol. 27, no. 1, pp. 43–52, 2022, [Online]. Available: https://sid.ir/paper/1114045/en